July 10, 2020 / 9:33 AM / a month ago

BRIEF-Insruance Unit Of Hubei Biocause Pharma Says Premium Income 22.1 Bln Yuan In H1

July 10 (Reuters) - Hubei Biocause Pharmaceutical Co Ltd :

* SAYS INSURANCE UNIT'S PREMIUM INCOME AT ABOUT 22.1 BILLION YUAN ($3.16 billion) IN H1 Source text in Chinese: bit.ly/3fgX7WR Further company coverage: ($1 = 7.0045 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below